Meeting
2020 ASCO Virtual Scientific Program
Neoadjuvant chemotherapy plus surgery for high-risk advanced gastric cancer: Long-term results of KDOG1001 trial.
Authors
Kei Hosoda
Department of Upper Gastrointestinal Surgery, Kitasato University School of Medicine, Sagamihara, Japan
Kei Hosoda , Mizutomo Azuma , Chikatoshi Katada , Kenji Ishido , Masahiro Niihara , Hideki Ushiku , Mikiko Sakuraya , Marie Washio , Takuya Wada , Akinori Watanabe , Wasaburo Koizumi , Satoshi Tanabe , Keishi Yamashita , Naoki Hiki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
000003642
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4521)
DOI
10.1200/JCO.2020.38.15_suppl.4521
Abstract #
4521
Poster Bd #
129
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
The association of renal function with safety and efficacy of cisplatin plus S-1 (CS) therapy and docetaxel plus cisplatin plus S-1 (DCS) therapy in patients with advanced gastric cancer (AGC): An exploratory analysis of JCOG1013.
First Author: Shuichi Hironaka
Poster
2019 Gastrointestinal Cancers Symposium
Primary results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 (CS) and docetaxel/cisplatin/S-1 (DCS) as neoadjuvant chemotherapy for locally advanced gastric cancer.
First Author: Takaki Yoshikawa
Poster
2019 Gastrointestinal Cancers Symposium
Long-term outcome of preoperative docetaxel with cisplatin plus S-1 therapy for advanced gastric cancer with extensive nodal metastasis (JCOG1002).
First Author: Shinji Morita
Poster
2018 ASCO Annual Meeting
Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013).
First Author: Yasuhide Yamada